Furthermore, RIP-seq analysis confirmed the interaction between IGF2BP2 and HMGA1 mRNA (Fig. 6F), and knockdown of IGF2BP2 increased HMGA1 mRNA degradation in BC cells treated with actinomycin D (Fig. 6G and S5C). The gene discussed is HMGA1; the disease is breast cancer.